Changes in biomarkers of bone resorption over the first six months after pediatric hematopoietic cell transplantation

Pediatric Transplantation

Volumn 16, Issue 8, 2012, Pages 852-857

  Polgreen, L E ^a   Rudser, K ^b   Deyo, M ^a   Smith, A ^c   Baker, K S ^d   Petryk, A ^a  

^a Division of Endocrinology   (United States)

^b School of Public Health   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

bone; bone marrow transplantation; bone resorption; osteoporosis; pediatric

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; CARBOXY TERMINAL TELOPEPTIDE; CREATININE; DEOXYPYRIDINOLINE; PYRIDINOLINE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; OSTEOLYSIS; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCHOOL CHILD; URINE LEVEL;

ADOLESCENT; ANEMIA, APLASTIC; BIOLOGICAL MARKERS; BONE DENSITY; BONE RESORPTION; CHILD; FANCONI ANEMIA; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOMEOSTASIS; HUMANS; LEUKEMIA; LYMPHOMA; MALE; OSTEOPOROSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84868704030     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2012.01780.x     Document Type: Article

References (22)

1. Stern JM, Sullivan KM, Ott SM, et al., Bone density loss after allogeneic hematopoietic stem cell transplantation: A prospective study. Biol Blood Marrow Transplant 2001: 7: 257-264.
2. Nysom K, Holm K, Michaelsen KF, et al., Bone mass after allogeneic BMT for childhood leukaemia or lymphoma. Bone Marrow Transplant 2000: 25: 191-196.
3. Bhatia S, Ramsay NK, Weisdorf D, Griffiths H, Robison LL,. Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies. Bone Marrow Transplant 1998: 22: 87-90.
4. Petryk A, Bergemann TL, Polga KM, et al., Prospective study of changes in bone mineral density and turnover in children after hematopoietic cell transplantation. J Clin Endocrinol Metab 2006: 91: 899-905.
5. Kaste SC, Shidler TJ, Tong X, et al., Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant 2004: 33: 435-441.
6. Perkins JL, Kunin-Batson AS, Youngren NM, et al., Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age. Pediatr Blood Cancer 2007: 49: 958-963.
7. Daniels MW, Wilson DM, Paguntalan HG, Hoffman AR, Bachrach LK,. Bone mineral density in pediatric transplant recipients. Transplantation 2003: 76: 673-678.
8. Goulding A, Jones IE, Taylor RW, Manning PJ, Williams SM,. More broken bones: A 4-year double cohort study of young girls with and without distal forearm fractures. J Bone Miner Res 2000: 15: 2011-2018.
9. Clark EM, Ness AR, Bishop NJ, Tobias JH,. Association between bone mass and fractures in children: A prospective cohort study. J Bone Miner Res 2006: 21: 1489-1495.
10. Bachrach LK, Hastie T, Wang MC, Narasimhan B, Marcus R,. Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: A longitudinal study. J Clin Endocrinol Metab 1999: 84: 4702-4712.
11. Kang MI, Lee WY, Oh KW, et al., The short-term changes of bone mineral metabolism following bone marrow transplantation. Bone 2000: 26: 275-279.
12. Ebeling PR, Thomas DM, Erbas B, Hopper JL, Szer J, Grigg AP,. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation. J Bone Miner Res 1999: 14: 342-350.
13. Greulich WW, Pyle SI,. Radiographic Atlas of Skeletal Development of the Hand and Wrist. Stanford, CA: Stanford University Press, 1959.
14. T eam RDC. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing, 2011.
15. Valimaki MJ, Kinnunen K, Volin L, et al., A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: Effect of calcium supplementation with or without calcitonin. Bone Marrow Transplant 1999: 23: 355-361.
16. Kananen K, Volin L, Laitinen K, Alfthan H, Ruutu T, Valimaki MJ,. Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate. J Clin Endocrinol Metab 2005: 90: 3877-3885.
17. Grigg AP, Shuttleworth P, Reynolds J, et al., Pamidronate reduces bone loss after allogeneic stem cell transplantation. J Clin Endocrinol Metab 2006: 91: 3835-3843.
18. Chae YS, Kim JG, Moon JH, et al., Pilot study on the use of zoledronic acid to prevent bone loss in allo-SCT recipients. Bone Marrow Transplant 2009: 44: 35-41.
19. D'Souza AB, Grigg AP, Szer J, Ebeling PR,. Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation. Intern Med J 2006: 36: 600-603.
20. Tauchmanova L, Ricci P, Serio B, et al., Short-term zoledronic acid treatment increases bone mineral density and marrow clonogenic fibroblast progenitors after allogeneic stem cell transplantation. J Clin Endocrinol Metab 2005: 90: 627-634.
21. Tauchmanova L, De SimoneG, Musella T, et al., Effects of various antireabsorptive treatments on bone mineral density in hypogonadal young women after allogeneic stem cell transplantation. Bone Marrow Transplant 2006: 37: 81-88.
22. Carpenter PA, Hoffmeister P, Chesnut CH 3rd, et al., Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease. Biol Blood Marrow Transplant 2007: 13: 683-690.